| Expression pattern: |
UP |
| Associated gene: |
AGO2 |
| Associated microRNA: |
miR-29b |
| Biological function: |
inhibits osteogenic differentiation of BMSCs and in vivo bone formation |
| Molecular mechanism: |
Acts as a miRNA sponge for miR-29b (ceRNA mechanism), supported by luciferase reporter assay and cytoplasmic co-localization by FISH. |
| Biological pathway or process: |
osteogenesis (inhibits); ceRNA regulation (promotes) |
| Detected method: |
Q
S
M
|
| Validation methods: |
RT-qPCR; RNase R Treatment; FISH / smFISH; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; In Vivo Animal Model; H&E Staining; Oil Red O Staining; RNA-seq; Microarray |
| Clinical significance: |
circSOD2 may represent a promising and noninvasive biomarker for MAFLD |
| Description: |
circSOD2 (hsa_circ_0004662) is up-regulated in MAFLD liver/primary hepatocytes and can be delivered from hepatocytes to BMSCs. It suppresses osteogenic differentiation and in vivo bone formation by sponging miR-29b, supported by RIP/RAP, luciferase reporter assays, and cytoplasmic co-localization by FISH. |
| Confidence score: |
0.7385 |